Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_assertion type Assertion NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_head.
- NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_assertion description "[After treatments were completed, ELISA method was used to examine the concentration of VEGF-C in plasma and immunohistochemical method to examine microvessel density (MVD), lymphtic vessel density (LVD) of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_provenance.
- NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_assertion evidence source_evidence_literature NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_provenance.
- NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_assertion SIO_000772 17393109 NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_provenance.
- NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_assertion wasDerivedFrom befree-20140225 NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_provenance.
- NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_assertion wasGeneratedBy ECO_0000203 NP559267.RAHXekETYmABHnDopMqUDzLTF-hIbTZv9h_cI4Zw4eWSY130_provenance.